Rare pancreatic tumors

Article written and reviewed by Dr Luca Moretti

Rare pancreatic tumors comprise a heterogeneous group of neoplasms characterized by low incidence, marked biological heterogeneity, and distinctive diagnostic and therapeutic challenges. Unlike pancreatic ductal carcinoma, which is by far the most common pancreatic malignancy, these entities arise from different cell lineages and histological compartments, including acinar cells, squamous components, mesenchymal tissues, embryonal elements, and lymphoid tissue. Their rarity, together with the anatomical complexity of the pancreas and the frequent clinical overlap with more common tumors, often makes a multidisciplinary specialist approach and an extensive diagnostic work-up necessary, based on advanced imaging, comprehensive pathological assessment, and immunohistochemical and molecular characterization. The following sections present the main categories of rare primary and secondary pancreatic tumors, each linked to its dedicated in-depth monograph.

Pancreatic acinar cell carcinoma
Pancreatic acinar cell carcinoma is a rare neoplasm arising from exocrine acinar cells and is distinct from ductal carcinoma in its morphological, biological, and molecular features. It may present as a large mass with symptoms caused by compression of adjacent structures or, less commonly, with systemic manifestations related to enzyme hypersecretion. Diagnosis is based on specific histological and immunohistochemical criteria that distinguish it from other pancreatic neoplasms. The dedicated monograph examines its epidemiological, pathogenetic, clinical, and therapeutic aspects in detail.

Solid pseudopapillary neoplasm of the pancreas
Solid pseudopapillary neoplasm of the pancreas is a rare low-grade malignant tumor, typically diagnosed in young people and with a marked female predominance. It is characterized by slow growth and generally indolent biological behavior, although invasive potential is present in a minority of cases. Diagnosis is based on distinctive histological features and a characteristic immunophenotypic profile. Treatment is primarily surgical, and the prognosis is generally favorable.

Pancreatic adenosquamous carcinoma
Pancreatic adenosquamous carcinoma is a rare aggressive variant characterized by the coexistence of glandular and squamous components. It has unfavorable biological behavior and is often diagnosed at an advanced stage. Clinically, its symptoms overlap with those of pancreatic ductal carcinoma, making early recognition difficult. Diagnosis requires accurate histological confirmation, and treatment follows multimodal oncological approaches.

Undifferentiated pancreatic carcinoma
Undifferentiated pancreatic carcinoma comprises a group of highly aggressive neoplasms characterized by marked cellular atypia and the absence of recognizable glandular differentiation. It is associated with rapid clinical progression and a generally unfavorable prognosis. Diagnosis is complex and requires extensive histological and immunohistochemical assessment to exclude other entities. Treatment is based mainly on systemic strategies.

Undifferentiated pancreatic carcinoma with osteoclast-like giant cells
This rare variant of undifferentiated pancreatic carcinoma is characterized by multinucleated giant cells resembling osteoclasts. Despite its distinctive histological appearance, its biological behavior may be heterogeneous, and some cases are associated with a relatively better prognosis than other undifferentiated forms. Diagnosis is based on specific morphological and immunophenotypic criteria. Treatment requires a multidisciplinary approach.

Pancreatoblastoma
Pancreatoblastoma is a rare embryonal neoplasm that predominantly affects children, although it may occasionally occur in adults. It is characterized by complex histological architecture and marked biological aggressiveness. Clinical presentation may include large abdominal masses and compressive symptoms. Diagnosis and treatment require referral centers with specific expertise.

Primary pancreatic lymphoma
Primary pancreatic lymphoma is an exceptional entity arising from neoplastic proliferation of pancreatic lymphoid tissue. It may clinically and radiologically mimic epithelial pancreatic neoplasms. Diagnosis is based on biopsy with immunophenotypic and molecular characterization. Treatment is primarily systemic and depends on the lymphoma subtype.

Primary pancreatic sarcomas
Primary pancreatic sarcomas arise from mesenchymal tissues and comprise several extremely rare histological entities. They often present as large pancreatic masses and may cause compressive symptoms or abdominal pain. Diagnosis requires adequate biopsy specimens and detailed immunohistochemical characterization. Treatment is primarily surgical within a multidisciplinary framework.

Pancreatic metastases
Pancreatic metastases represent secondary involvement of the organ by primary extrapancreatic neoplasms. Although uncommon, they are clinically important because they may mimic primary pancreatic tumors. Diagnosis requires an integrated clinical, radiological, and histological assessment. Treatment depends on the primary tumor and the extent of disease.

Taken together, rare pancreatic tumors constitute a field of considerable clinical and scientific complexity in which correct identification of the histologic type and multidisciplinary assessment are decisive for treatment selection and prognosis. Detailed knowledge of these entities helps reduce diagnostic errors, avoid inappropriate treatments, and improve the overall management of patients.

References
1. Adsay NV et al. Acinar cell carcinoma of the pancreas: clinicopathologic analysis. Am J Surg Pathol. 26(7), 2002, 789–798.
2. WHO Classification of Tumours Editorial Board. Digestive System Tumours. IARC Press, Lyon, 2019.
3. Law JK et al. Solid-pseudopapillary neoplasm of the pancreas: a single-institution experience. Am J Surg. 206(6), 2013, 1030–1037.
4. Katz MH et al. Adenosquamous carcinoma of the pancreas: clinical features and outcomes. J Gastrointest Surg. 15(1), 2011, 109–118.
5. Lüttges J et al. Undifferentiated carcinoma of the pancreas. Virchows Arch. 444(5), 2004, 445–453.
6. Muraki T et al. Pancreatic carcinoma with osteoclast-like giant cells. Cancer. 94(3), 2002, 665–673.
7. Dhebri AR et al. Pancreatoblastoma in adults. Eur J Surg Oncol. 30(7), 2004, 749–753.
8. Saif MW et al. Primary pancreatic lymphoma. JOP. 11(6), 2010, 516–521.
9. Miettinen M et al. Mesenchymal tumors of the pancreas. Semin Diagn Pathol. 33(2), 2016, 121–129.
10. Hiotis SP et al. Metastatic disease to the pancreas. Ann Surg Oncol. 9(7), 2002, 675–680.